| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/21/2008 | CN101182355A Antibacterial peptide fusion protein gene, recombinant carrier thereof, transformant and expression product thereof |
| 05/21/2008 | CN101182351A Antibiotic peptide as well as preparation method and application thereof |
| 05/21/2008 | CN101182349A Recombinant octreotide and uses thereof |
| 05/21/2008 | CN101181636A Compound vaccine composition for preventing and controlling human viral infection, compound vaccine vaginal mist and uses thereof |
| 05/21/2008 | CN101181634A Application of proline isomerase in the preparation of antineoplastic medicament |
| 05/21/2008 | CN101181633A Chinese medicine paste for curing oral cavity disease and preparation method thereof |
| 05/21/2008 | CN101181632A Method for preparing superoxide dismutase microcapsule |
| 05/21/2008 | CN101181631A Compound prescription for preventing and improving osteosporosis as well as preparation method thereof |
| 05/21/2008 | CN101181630A Method for preparing collagen polypeptide products as well as usage |
| 05/21/2008 | CN101181629A Medicament abundantly containing FN for curing cervical erosion gynecopathy |
| 05/21/2008 | CN101181628A Application of human affinity prime in the preparation of anti-cancer medicament |
| 05/21/2008 | CN101181627A Application of human affinity prime in the preparation of resistance liver cancer medicament |
| 05/21/2008 | CN101181626A Transfer factor capsule and preparation method thereof |
| 05/21/2008 | CN101181370A Medicine for treating colitis |
| 05/21/2008 | CN101181281A Usage of eleutheroside with anti-inflammatory action or aglycone thereof |
| 05/21/2008 | CN101181269A Methods of treating cancer using an fpt inhibitor and antineoplastic agents |
| 05/21/2008 | CN101181263A Treatment of respiratory diseases |
| 05/21/2008 | CN101181236A Exendin agonist peptide formulations and administration method thereof |
| 05/21/2008 | CN101181227A Solid lipid nanometer particle in-situ gel rubber preparations of biological adherent cyclosporine A and preparation method thereof |
| 05/21/2008 | CN100389198C Streptococcal C5a peptidase vaccine |
| 05/21/2008 | CN100389196C Cancer cell vaccine |
| 05/21/2008 | CN100389192C Substances for preventing and treating autoimmune diseases |
| 05/21/2008 | CN100389128C Fusion protein of single antibody-interleukin 2, its preparation and use |
| 05/21/2008 | CN100389126C Endothelial cell proliferation inhibitor and method of use |
| 05/21/2008 | CN100389125C Rana grahami propyl sperm peptide, gene and variant and its pharmaceutical use |
| 05/21/2008 | CN100388951C Dietetic food composition and dietetic method using such composition |
| 05/21/2008 | CN100388950C Application of human urokinase-type peptidase in preparing medicine for treating diabetes combined cerebral infraction |
| 05/21/2008 | CN100388949C Lysostaphin freeze dried powder used for preventing and treating cattle edometritis |
| 05/21/2008 | CN100388948C Application of polygonatum cyrtonema Hua. Lectin II protein in medicine preparation for treating or preventing AIDS |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375204 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |
| 05/20/2008 | US7375195 Vectors with DNA encoding pro polypeptides |
| 05/20/2008 | US7375191 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
| 05/20/2008 | US7375189 administering adiponectin, which inhibits the actions of TGFB and PDGF on hepatic stellate cells and thereby exerts effects of suppressing hepatic fibrosis and promoting the proliferation of normal hepatocytes; treating liver cirrhosis or chronic hepatitis |
| 05/20/2008 | US7375186 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 05/20/2008 | US7375185 Comprises cardiac mysosin light chain kinase protein for use in identification, treatment and prevention of cardiac hypertrophy, cardiomyopathy and congestive heart failure |
| 05/20/2008 | US7375182 Growth factor homolog zvegf4 |
| 05/20/2008 | US7375181 Process for purifying glycopeptide phosphonate derivatives |
| 05/20/2008 | US7375180 Selecting a compound identified as a TLR8 agonist; andadministering to the cell the compound in an amount that affects at least one TLR8-mediated cellular signaling pathway for eliciting a TLR8-mediated cellular response in a cell |
| 05/20/2008 | US7375179 PRO19680 polypeptides |
| 05/20/2008 | US7375137 Methods of treating cancer with HDAC inhibitors |
| 05/20/2008 | US7375117 Polypeptides |
| 05/20/2008 | US7375092 Blocking mitosis; transfection nucleic acid; anticancer agents |
| 05/20/2008 | US7375091 Comprising a HER-2/neu extracellular domain fused to a HER-2/neu phosphorylation domain, wherein the protein is capable of producing an immune response in a warm-blooded animal. |
| 05/20/2008 | US7375086 Comprises muropeptides which activate nuclear factor kappa B; drug screening; inflammatory bowel diseases; Nucleotide sequences coding protein for use in the treatment of crohn's disease |
| 05/20/2008 | US7375085 Melanocyte-stimulating hormone inhibitors |
| 05/20/2008 | US7375083 Pharmaceutical compositions for prevention of overdose or abuse |
| 05/20/2008 | US7375082 Administering composition comprising hydrocodone covalently bound to a single amino acid or an oligopeptide of 15 or fewer amino acids through the N-terminus or side chain of oligopeptide or amino acid; decreasing the bioavailability by intravenous or intranasal administration |
| 05/20/2008 | US7375081 Synergist mixture with lipopeptide and cyclic hexapeptide |
| 05/20/2008 | US7375080 Microbiocides; reducing microorganisms in foods |
| 05/20/2008 | US7375079 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression |
| 05/20/2008 | US7375078 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 05/20/2008 | US7375077 In vivo synthesis of connective tissues |
| 05/20/2008 | US7375076 Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein |
| 05/20/2008 | US7375074 Ligand which binds to polypeptides; controlling eating disorders; screening process |
| 05/20/2008 | US7375073 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| 05/20/2008 | US7374932 Human kinases and polynucleotides encoding the same, and uses thereof |
| 05/20/2008 | US7374930 GLP-1 gene delivery for the treatment of type 2 diabetes |
| 05/20/2008 | US7374912 Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/20/2008 | US7374911 Cytokine polypeptide for use in diagnosis, prevention and treatment of immunological and/or inflammatory disorders |
| 05/20/2008 | US7374910 agonist; a memory function improving agent, appetite regulator; an uterine, renal, testis, spleen, heart, prostatic or skeletal muscle function improving agent; antiobesity agent, antiabetic |
| 05/20/2008 | US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector |
| 05/20/2008 | US7374901 the reduced ubiquinol form has antiaging effect such as the prevention of cellular damage caused by active oxygen and is a good marker for oxidation stress; solvent extraction in isopropyl alcohol from blood sample; reduction; chromatography; accuracy |
| 05/20/2008 | US7374898 Peptide inhibitors against seprase |
| 05/20/2008 | US7374894 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 05/20/2008 | US7374892 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/20/2008 | US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay |
| 05/20/2008 | US7374884 mutant alleles of the angiotensinogen (AGT) gene which cause susceptibility to insulin-dependent diabetes mellitus (IDDM); drug screening, diagnosis |
| 05/20/2008 | US7374875 Peptides having affinity for the gp120 viral protein and use thereof |
| 05/20/2008 | US7374874 Bacteriophages that infect Bacillus bacteria (Anthrax) |
| 05/20/2008 | US7374872 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 05/20/2008 | US7374779 Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| 05/20/2008 | US7374774 Electroprocessed material made by simultaneously electroprocessing a natural protein polymer and two synthetic polymers |
| 05/20/2008 | US7374769 Method for treating a trigeminal neuralgia by peripheral administration of a neurotoxin |
| 05/20/2008 | US7374767 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN |
| 05/20/2008 | US7374765 Methods and compositions for diagnosis and treatment of iron misregulation diseases |
| 05/20/2008 | US7374764 CD33-like protein |
| 05/20/2008 | US7374763 Foot-and-Mouth Disease virus (FMDV), or their epitopes; vaccine from the grafting of peptide epitopes derived from FMDV into swine antibody CDR loops, FMDV peptide epitopes are cloned by polymerace chain reaction PCR from VP1 gene of FMDV |
| 05/20/2008 | US7374761 Antigen-binding fragment (immunoglobulin) which bind to epitope of tumor necrosis factor (TNF) and inhibits its activity; diagnosis and treatment |
| 05/20/2008 | US7374760 Methods and compositions for nerve regeneration |
| 05/20/2008 | US7374758 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders |
| 05/20/2008 | US7374757 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF) to patient in need thereof, wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and a multimerizing component; eye disorders |
| 05/20/2008 | US7374754 Administering topical or by injection; regenerating strength, thickness of aging skins |
| 05/20/2008 | US7374751 QS-21 and IL-12 as an adjuvant combination |
| 05/20/2008 | CA2589987C Method for treating a cholinergic influenced secretion |
| 05/20/2008 | CA2569080A1 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus |
| 05/20/2008 | CA2438218C Modulated release particles for aerosol delivery |
| 05/20/2008 | CA2366862C Transdermal therapeutic system and process for its production |
| 05/20/2008 | CA2331333C Antisense oligonucleotide constructs based on .beta.-arabinofuranose and its analogues |
| 05/20/2008 | CA2294480C Microdose therapy of female sexual dysfunction by no, co, and their donors |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2222755C Separation of hemoglobin on hydroxyapatite using hplc |
| 05/20/2008 | CA2219819C Novel compounds, the preparation and use thereof |
| 05/20/2008 | CA2219818C Novel compounds, the preparation and use thereof |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/20/2008 | CA2172630C Cellular and serum protein anchors and conjugates |
| 05/20/2008 | CA2166931C Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 05/20/2008 | CA2159610C Prodrugs with enhanced penetration into cells |
| 05/15/2008 | WO2008057609A2 Methods of treating neuronal disorders using mntf peptides and analogs thereof |
| 05/15/2008 | WO2008057608A2 Synthetic peptide amides |